Incuron, LLC Announces

  • 27.11.2015

Incuron Announces Notice of Allowance from FDA to Commence Clinical Trials of CBL0137.

Results in Study of Pediatric Neuroblastoma

  • 17.11.2015

Incuron Announces Results in Study of Pediatric Neuroblastoma, that have been published in the journal Science Translational Medicine. The reported studies were led by scientists from the Children’s Cancer Institute–Australia (CCIA),Roswell Park Cancer Institute (RPCI) and Incuron.

Cell Reports Publication

  • 11.02.2015

Cell Reports Publication Elucidates Role of FACT as Accelerator of Tumor Transformation and Potential Marker and Target of Aggressive Cancers

Incuron, LLC announces

  • 09.08.2011

Incuron, LLC announces start of a phase Ib safety and tolerability trial for curaxin CBL0102 in patients with liver tumors of different etiology in Russia